M&A
Signant Health Acquires Ametris To Create End-To-End eCOA And Wearables Platform
June 25, 2026
Biotech
M&A
Key Facts
Signal Type
M&A
Industry
Biotech
Companies
Signant Health, Ametris
Date
June 25, 2026
Signant Health acquired Ametris (formerly ActiGraph) on May 14, 2026. This merger combines Signant's eCOA solutions with Ametris' wearable-derived digital outcome measures, creating a unified platform for clinical trials.
Clinical trial sponsors and CROs are the primary beneficiaries. They now have access to a single provider offering integrated patient-reported outcomes and continuous sensor data, reducing the complexity of managing multiple vendors.
Near-term priorities include unified data flows and workflows, coordinated deployment tools, and integrated analytics. Future developments may involve AI and machine learning algorithms for novel digital and composite outcome measures.
Source:
Clinical LeaderGet biotech signals in your CRM
FDA approvals and rejections, clinical trial results, pharma M&A, drug recalls, and funding rounds.
